Tapewire

NYSE · USD

NVST

Envista Holdings Corp

Export transactions ↓
Tapewire entity
4007
SEC CIK
0001757073
Parsed reports
315

Last 12 months

Inside the activity.

0 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202602
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 10, 2026 Filed Feb 11, 2026 22:15 UTC
Reis MischaSVP, Strategy & Bus. Dev.
SaleCommon Stock 4,041 $30.00 $121,230.00
Disclosure

SEC source: 0001788632-26-000004 · wk-form4_1770848154.xml · nonDerivative · entry 2

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,382

F2 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

Read SEC document
February 10, 2026 Filed Feb 11, 2026 22:15 UTC
Reis MischaSVP, Strategy & Bus. Dev.
Exercise / conversionCommon Stock 4,041 $19.04 $76,940.64
Disclosure

SEC source: 0001788632-26-000004 · wk-form4_1770848154.xml · nonDerivative · entry 1

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,423

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: These Options were originally granted by Danaher and, pursuant to the terms of the Employee Matters Agreement, were adjusted into Options relating to shares of Issuer common stock in connection with the Separation.

Read SEC document
February 01, 2026 Filed Feb 4, 2026 02:03 UTC
Acurio VeronicaPresident, Orthodontics
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative 998 $23.47 $23,423.06
Disclosure

SEC source: 0002045846-26-000002 · wk-form4_1770170631.xml · derivative · entry 1

Acurio Veronica · CIK 0002045846 · President, Orthodontics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 998

Underlying: Common Stock · 998 shares

Expires not disclosed

F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made.

F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made.

F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account.

Read SEC document
February 01, 2026 Filed Feb 4, 2026 02:04 UTC
Befidi RobertPresident, Diagnostics
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative 998 $23.47 $23,423.06
Disclosure

SEC source: 0002012361-26-000002 · wk-form4_1770170663.xml · derivative · entry 1

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,149

Underlying: Common Stock · 998 shares

Expires not disclosed

F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made.

F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made.

F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account.

Read SEC document
February 01, 2026 Filed Feb 3, 2026 21:03 UTC
Kaabi Faez CChief Accounting Officer
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative 1,186 $23.47 $27,835.42
Disclosure

SEC source: 0001993528-26-000001 · wk-form4_1770170636.xml · derivative · entry 1

Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,040

Underlying: Common Stock · 1,186 shares

Expires not disclosed

F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntarily defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntarily defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made.

F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made.

F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account.

Read SEC document
February 01, 2026 Filed Feb 4, 2026 02:04 UTC
Hammes Eric D.Chief Financial Officer
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative 1,119 $23.47 $26,262.93
Disclosure

SEC source: 0001610493-26-000002 · wk-form4_1770170652.xml · derivative · entry 1

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,119

Underlying: Common Stock · 1,119 shares

Expires not disclosed

F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made.

F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made.

F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account.

Read SEC document
February 01, 2026 Filed Feb 4, 2026 02:04 UTC
Keel Paul ADirector · Chief Executive Officer
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative 4,091 $23.47 $96,015.77
Disclosure

SEC source: 0001626337-26-000002 · wk-form4_1770170646.xml · derivative · entry 1

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,091

Underlying: Common Stock · 4,091 shares

Expires not disclosed

F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made.

F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made.

F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account.

Read SEC document
February 01, 2026 Filed Feb 3, 2026 21:04 UTC
Nance Mark EGeneral Counsel
GrantEnvista deferred contribution programs - Envista Stock Fund · Derivative 2,006 $23.47 $47,080.82
Disclosure

SEC source: 0001755882-26-000002 · wk-form4_1770170641.xml · derivative · entry 1

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,587

Underlying: Common Stock · 2,006 shares

Expires not disclosed

F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F2 · derivative.exercise_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F2 · derivative.expiration_date: Company contributions to the Excess Contribution Program ("ECP") consist of matching contributions (based on amounts the reporting person voluntary defers into the Envista Deferred Compensation Plan) and/or non-elective contributions. A participant vests in the matching contribution in the ECP made each year on the first anniversary after it is credited to the participant's account. A participant vests in the non-elective contribution in the ECP made each year on the later of the first anniversary after it is credited to the participant's account, or the date the participant has completed three years of service with Envista.

F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made.

F3 · balance_after: Represents the Company's annual contribution to the Envista stock fund (the "ECP Stock Fund") in the reporting person's ECP account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last day in January of the year in which the contribution is made.

F4 · balance_after: Consists of unfunded, notional shares of Envista common stock in the Envista stock fund of the reporting person's ECP account.

Read SEC document
February 01, 2026 Filed Feb 4, 2026 02:04 UTC
Reis MischaSVP, Strategy & Bus. Dev.
GrantExecutive Deferred Incentive Program - Envista Stock Fund · Derivative 2,919 $21.71 $63,371.49
Disclosure

SEC source: 0001788632-26-000002 · wk-form4_1770170658.xml · derivative · entry 1

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,357

Underlying: Common Stock · 2,919 shares

Expires not disclosed

F1 · derivative.exercise_price: The notional shares convert on a one-for-one basis.

F2 · derivative.exercise_date: All contributions to the reporting person's EDIP Stock Fund are 90% vested and will vest at 10% each subsequent year on 1/1 until he reaches 10 years of EDIP participation or retirement eligibility. Upon termination of employment, the EDIP Stock Fund balance is settled in shares of Envista common stock.

F2 · derivative.expiration_date: All contributions to the reporting person's EDIP Stock Fund are 90% vested and will vest at 10% each subsequent year on 1/1 until he reaches 10 years of EDIP participation or retirement eligibility. Upon termination of employment, the EDIP Stock Fund balance is settled in shares of Envista common stock.

F3 · derivative.underlying_shares: Represents the Company's annual contribution to the Envista stock fund (the "EDIP Stock Fund") in the reporting person's Executive Deferred Incentive Program (the "EDIP") account. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Envista common stock, calculated by dividing the contribution amount by the closing price of Envista common stock as reported on the NYSE as of the last trading day of the prior year.

Read SEC document
November 01, 2025 Filed Nov 4, 2025 21:25 UTC
Keel Paul ADirector · Chief Executive Officer
Tax withholdingCommon Stock 54,097 $20.35 $1,100,873.95
Disclosure

SEC source: 0001626337-25-000003 · wk-form4_1762291503.xml · nonDerivative · entry 1

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 347,555

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 20:15 UTC
Nilsson StefanPresident, Nobel Biocare
Tax withholdingCommon Stock 804 $21.12 $16,980.48
Disclosure

SEC source: 0002045818-25-000003 · wk-form4_1756325732.xml · nonDerivative · entry 1

Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,941

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 20:13 UTC
Acurio VeronicaPresident, Orthodontics
Tax withholdingCommon Stock 5,422 $21.12 $114,512.64
Disclosure

SEC source: 0002045846-25-000003 · wk-form4_1756325598.xml · nonDerivative · entry 1

Acurio Veronica · CIK 0002045846 · President, Orthodontics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,323

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 20:19 UTC
Befidi RobertPresident, Diagnostics
Tax withholdingCommon Stock 3,454 $21.12 $72,948.48
Disclosure

SEC source: 0002012361-25-000003 · wk-form4_1756325973.xml · nonDerivative · entry 1

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,504

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 20:17 UTC
Hammes Eric D.Chief Financial Officer
Tax withholdingCommon Stock 7,654 $21.12 $161,652.48
Disclosure

SEC source: 0001610493-25-000003 · wk-form4_1756325855.xml · nonDerivative · entry 1

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,788

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.

Read SEC document
August 25, 2025 Filed Aug 27, 2025 20:09 UTC
Reis MischaSVP, Strategy & Bus. Dev.
SaleCommon Stock 15,000 $21.60 $324,000.00
Disclosure

SEC source: 0001788632-25-000003 · wk-form4_1756325384.xml · nonDerivative · entry 1

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,382

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.

Read SEC document
July 14, 2025 Filed Jul 16, 2025 20:17 UTC GrantCommon Stock 9,155 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-035071 · wk-form4_1752697042.xml · nonDerivative · entry 1

Pierce James Andrew · CIK 0001886518 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,155

F1 · shares: Consists of Restricted Stock Units ("RSUs") that were granted upon the Reporting Person's appointment as a director of the Issuer on July 14, 2025. The RSUs will vest on June 10, 2026. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:55 UTC
Jain VivekDirector
GrantCommon Stock 10,450 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-031066 · wk-form4_1749761728.xml · nonDerivative · entry 1

Jain Vivek · CIK 0001410442 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 43,615

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:55 UTC GrantCommon Stock 10,450 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-031063 · wk-form4_1749761708.xml · nonDerivative · entry 1

TSINGOS CHRISTINE A · CIK 0001278861 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,600

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:55 UTC GrantCommon Stock 10,450 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-031067 · wk-form4_1749761738.xml · nonDerivative · entry 1

Raskas Daniel · CIK 0001306860 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,680

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:55 UTC GrantCommon Stock 10,450 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-031069 · wk-form4_1749761747.xml · nonDerivative · entry 1

GALLAHUE KIERAN · CIK 0001308428 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,680

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:54 UTC GrantCommon Stock 14,370 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-031060 · wk-form4_1749761687.xml · nonDerivative · entry 1

Huennekens R Scott · CIK 0001365493 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,520

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:55 UTC GrantCommon Stock 10,450 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-031064 · wk-form4_1749761718.xml · nonDerivative · entry 1

Carruthers Wendy · CIK 0001563565 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,610

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:55 UTC GrantCommon Stock 10,450 $0.00 $0.00
Disclosure

SEC source: 0001628280-25-031062 · wk-form4_1749761698.xml · nonDerivative · entry 1

Hulit Barbara B. · CIK 0001682154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 79,820

F1 · shares: Consists of an annual equity grant of Restricted Stock Units ("RSUs") for the Reporting Person's service as a director of the Issuer. The RSUs will vest on the first anniversary of the grant date. RSUs are payable in shares of common stock on a one-to-one basis.

Read SEC document
May 25, 2025 Filed May 27, 2025 20:45 UTC
Keel Paul ADirector · Chief Executive Officer
Tax withholdingCommon Stock 12,787 $16.72 $213,798.64
Disclosure

SEC source: 0001628280-25-027962 · wk-form4_1748378753.xml · nonDerivative · entry 1

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 401,652

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units.

Read SEC document
February 26, 2025 Filed Feb 27, 2025 22:27 UTC
Reis MischaSVP, Strategy & Bus. Dev.
GrantCommon Stock 8,475 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000014 · wk-form4_1740695247.xml · nonDerivative · entry 2

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,382

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Nilsson StefanPresident, Nobel Biocare
GrantEmployee Stock Option (Right to Buy) · Derivative 24,010 $0.00 Strike: $20.66 $0.00
Disclosure

SEC source: 0001757073-25-000011 · wk-form4_1740695216.xml · derivative · entry 3

Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,010

Underlying: Common Stock · 24,010 shares

Expires 2035-02-25

F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Nilsson StefanPresident, Nobel Biocare
GrantPerformance Share Unit · Derivative 18,960 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000011 · wk-form4_1740695216.xml · derivative · entry 2

Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,960

Underlying: Common Stock · 18,960 shares

Expires not disclosed

F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Nilsson StefanPresident, Nobel Biocare
GrantCommon Stock 10,290 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000011 · wk-form4_1740695216.xml · nonDerivative · entry 1

Nilsson Stefan · CIK 0002045818 · President, Nobel Biocare

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,745

F1 · shares: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Acurio VeronicaPresident, Orthodontics
GrantEmployee Stock Option (Right to Buy) · Derivative 24,010 $0.00 Strike: $20.66 $0.00
Disclosure

SEC source: 0001757073-25-000012 · wk-form4_1740695226.xml · derivative · entry 3

Acurio Veronica · CIK 0002045846 · President, Orthodontics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,010

Underlying: Common Stock · 24,010 shares

Expires 2035-02-25

F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Acurio VeronicaPresident, Orthodontics
GrantPerformance Share Unit · Derivative 18,960 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000012 · wk-form4_1740695226.xml · derivative · entry 2

Acurio Veronica · CIK 0002045846 · President, Orthodontics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,960

Underlying: Common Stock · 18,960 shares

Expires not disclosed

F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Acurio VeronicaPresident, Orthodontics
GrantCommon Stock 10,290 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000012 · wk-form4_1740695226.xml · nonDerivative · entry 1

Acurio Veronica · CIK 0002045846 · President, Orthodontics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,745

F1 · shares: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:26 UTC
Befidi RobertPresident, Diagnostics
GrantEmployee Stock Option (Right to Buy) · Derivative 24,010 $0.00 Strike: $20.66 $0.00
Disclosure

SEC source: 0001757073-25-000010 · wk-form4_1740695207.xml · derivative · entry 4

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,010

Underlying: Common Stock · 24,010 shares

Expires 2035-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:26 UTC
Befidi RobertPresident, Diagnostics
GrantPerformance Share Unit · Derivative 18,960 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000010 · wk-form4_1740695207.xml · derivative · entry 3

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,960

Underlying: Common Stock · 18,960 shares

Expires not disclosed

F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:26 UTC
Befidi RobertPresident, Diagnostics
GrantCommon Stock 10,290 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000010 · wk-form4_1740695207.xml · nonDerivative · entry 2

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,958

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:26 UTC
Befidi RobertPresident, Diagnostics
Tax withholdingCommon Stock 1,123 $20.66 $23,201.18
Disclosure

SEC source: 0001757073-25-000010 · wk-form4_1740695207.xml · nonDerivative · entry 1

Befidi Robert · CIK 0002012361 · President, Diagnostics

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,668

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
February 25, 2025 Filed Feb 27, 2025 17:27 UTC
Kaabi Faez CChief Accounting Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 22,600 $0.00 Strike: $20.66 $0.00
Disclosure

SEC source: 0001757073-25-000015 · wk-form4_1740695258.xml · derivative · entry 3

Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,600

Underlying: Common Stock · 22,600 shares

Expires 2035-02-25

F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 17:27 UTC
Kaabi Faez CChief Accounting Officer
GrantCommon Stock 9,685 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000015 · wk-form4_1740695258.xml · nonDerivative · entry 2

Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 49,996

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 17:27 UTC
Kaabi Faez CChief Accounting Officer
Tax withholdingCommon Stock 4,319 $20.66 $89,230.54
Disclosure

SEC source: 0001757073-25-000015 · wk-form4_1740695258.xml · nonDerivative · entry 1

Kaabi Faez C · CIK 0001993528 · Chief Accounting Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,311

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSUs").

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:26 UTC
Hammes Eric D.Chief Financial Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 36,720 $0.00 Strike: $20.66 $0.00
Disclosure

SEC source: 0001757073-25-000009 · wk-form4_1740695196.xml · derivative · entry 3

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,720

Underlying: Common Stock · 36,720 shares

Expires 2035-02-25

F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:26 UTC
Hammes Eric D.Chief Financial Officer
GrantPerformance Share Unit · Derivative 28,995 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000009 · wk-form4_1740695196.xml · derivative · entry 2

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,995

Underlying: Common Stock · 28,995 shares

Expires not disclosed

F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:26 UTC
Hammes Eric D.Chief Financial Officer
GrantCommon Stock 15,735 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000009 · wk-form4_1740695196.xml · nonDerivative · entry 1

Hammes Eric D. · CIK 0001610493 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,442

F1 · shares: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Keel Paul ADirector · Chief Executive Officer
GrantEmployee Stock Option (Right to Buy) · Derivative 153,660 $0.00 Strike: $20.66 $0.00
Disclosure

SEC source: 0001757073-25-000013 · wk-form4_1740695237.xml · derivative · entry 3

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,660

Underlying: Common Stock · 153,660 shares

Expires 2035-02-25

F3 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Keel Paul ADirector · Chief Executive Officer
GrantPerformance Share Unit · Derivative 181,985 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000013 · wk-form4_1740695237.xml · derivative · entry 2

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,985

Underlying: Common Stock · 181,985 shares

Expires not disclosed

F2 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F2 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F2 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Keel Paul ADirector · Chief Executive Officer
GrantCommon Stock 65,830 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000013 · wk-form4_1740695237.xml · nonDerivative · entry 1

Keel Paul A · CIK 0001626337 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 414,439

F1 · shares: Consists of Restricted Stock Units ("RSUs") that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 17:26 UTC
Nance Mark EGeneral Counsel
GrantEmployee Stock Option (Right to Buy) · Derivative 42,370 $0.00 Strike: $20.66 $0.00
Disclosure

SEC source: 0001757073-25-000008 · wk-form4_1740695186.xml · derivative · entry 4

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,370

Underlying: Common Stock · 42,370 shares

Expires 2035-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 17:26 UTC
Nance Mark EGeneral Counsel
GrantPerformance Share Unit · Derivative 33,455 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000008 · wk-form4_1740695186.xml · derivative · entry 3

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,455

Underlying: Common Stock · 33,455 shares

Expires not disclosed

F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 17:26 UTC
Nance Mark EGeneral Counsel
GrantCommon Stock 18,155 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000008 · wk-form4_1740695186.xml · nonDerivative · entry 2

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,945

F2 · shares: Consists of RSUs that will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date. Each RSU will convert on a 1-for-1 basis, in shares of the Issuer's common stock.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 17:26 UTC
Nance Mark EGeneral Counsel
Tax withholdingCommon Stock 3,691 $20.66 $76,256.06
Disclosure

SEC source: 0001757073-25-000008 · wk-form4_1740695186.xml · nonDerivative · entry 1

Nance Mark E · CIK 0001755882 · General Counsel

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,790

F1 · shares: Represents shares of the Issuer's common stock withheld to satisfy tax withholding obligations applicable to the vesting of stock-settled Restricted Stock Units ("RSU").

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Reis MischaSVP, Strategy & Bus. Dev.
GrantEmployee Stock Option (Right to Buy) · Derivative 19,780 $0.00 Strike: $20.66 $0.00
Disclosure

SEC source: 0001757073-25-000014 · wk-form4_1740695247.xml · derivative · entry 4

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,780

Underlying: Common Stock · 19,780 shares

Expires 2035-02-25

F4 · derivative.exercise_date: This Option will vest ratably on each anniversary of the date of grant over three years, subject to continued service through each such date.

Read SEC document
February 25, 2025 Filed Feb 27, 2025 22:27 UTC
Reis MischaSVP, Strategy & Bus. Dev.
GrantPerformance Share Unit · Derivative 15,615 $0.00 $0.00
Disclosure

SEC source: 0001757073-25-000014 · wk-form4_1740695247.xml · derivative · entry 3

Reis Mischa · CIK 0001788632 · SVP, Strategy & Bus. Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,615

Underlying: Common Stock · 15,615 shares

Expires not disclosed

F3 · derivative.exercise_price: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.exercise_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

F3 · derivative.expiration_date: Consists of Performance Share Units that will vest, if at all, based on certification of achievement of identified performance measures over a three-year performance period. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-200% of the amount reported depending on the level of performance achieved.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.